Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

Bayer is pressing ahead with a phase 3 trial ... most apparent in the highest (50 mg) dose group where the risk was reduced by a third. In PACIFIC-AMI, asundexian was unable to reduce the main ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...

Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...

Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) must pay $100M to four people who say they were sickened by exposure to toxic PCB chemicals made by Monsanto that were used in light fixtures at a Seattle-area school ...

Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...